Fosun relists ClubMed as standalone, but valuation may be hard
Fosun relists ClubMed as a standalone business about a year after privatising its tourism unit. TradingView News notes that matching valuations of faster-growing, more profitable hotel chains may be difficult.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.